Rheumatological Manifestations in Inflammatory Bowel Diseases

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03486652

Enrollment

Registered

2018-04-03

Start date

2018-05-01

Completion date

2019-04-01

Last updated

2018-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory Bowel Diseases

Brief summary

IBD-related arthropathy is one of a group of inflammatory arthritides considered as seronegative spondyloarthropathies, a group of disorders that also includes ankylosing spondylitis, psoriatic arthritis, reactive arthritis, and undifferentiated SpA. IBD-related SpA is mainly characterized by axial involvement but may also be associated with peripheral symptoms, such as synovitis, dactylitis, or enthesitis

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* any patient with inflammatory bowel diseases complaining of rheumatological manifestations

Exclusion criteria

* chronic hepatitis (c) patients * Rheumatoid factor positive patients * psoriatic patients. * systemic lupus.

Design outcomes

Primary

Measure	Time frame	Description
the prevalence of rheumatological manifestations in cases of corhn's and ulcerative colitis	one year	evaluation of all cases for manifestations of rheumatological manifestations

Outcome results